A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
formats

Boston Scientific’s Proprietary Batteries Projected to Give >10 Year Longevity to ICDs

Boston Scientific announced today that FDA has approved revised product labeling for  its INCEPTA™, ENERGEN™, PUNCTUA™, COGNIS® and TELIGEN® ICDs and CRT-Ds to reflect increased longevity projections for these devices.  The longevity projections are based on data submitted to the FDA and vary for each device dependent on the model type and settings.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific’s Proprietary Batteries Projected to Give >10 Year Longevity to ICDs  comments 
formats

FCC Considering Opening Spectrum to Wireless Body Sensors

Reported by dotMedNews.com:  FCC could open spectrum to wireless body sensors May       18, 2012 by Brendon Nafziger, DOTmed News Associate Editor Patients in intensive care units are typically festooned with a mass of monitoring wires, leads, pads and electrodes. Not only is this an infection control hazard, which some researchers estimate costs the industry billions

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on FCC Considering Opening Spectrum to Wireless Body Sensors  comments 
formats

Smallest ICD (30cc) – St. Jude’s Ellipse – Receives FDA Approval

St. Jude today announced FDA approval of its Ellipse™ ICD.  The device’s shape was designed with feedback from more than 200 physicians from around the world.  The Ellipse ICD offers physicians unique design advancements, resulting in a high-energy ICD that occupies barely 30cc. According to the announcement, “The Ellipse ICD’s unique shape was conceptualized by physicians during focus groups

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Smallest ICD (30cc) – St. Jude’s Ellipse – Receives FDA Approval  comments 
formats

FDA Approves St. Jude’s Assura™ ICDs That Reduce Inappropriate Shocks

St. Jude Medical today announced FDA approval of its Assura™ portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).The new implantable defibrillators feature SecureSense™ RV Lead Noise Discrimination, an algorithm that expands the St. Jude Medical ShockGuard® Technology and offers advanced sensing options designed to reduce the incidence of inappropriate shocks for patients

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on FDA Approves St. Jude’s Assura™ ICDs That Reduce Inappropriate Shocks  comments